Interim Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024
Revenues:
Net patient revenues	$ 363,349,000	$ 279,918,000	$ 724,956,000	$ 565,741,000
Other revenues	11,561,000	11,295,000	23,651,000	22,648,000
Government stimulus income	0	9,445,000	0	9,445,000
Net operating revenues and grant income	374,910,000	300,658,000	748,607,000	597,834,000
Costs and expenses:
Salaries, wages, and benefits	226,534,000	180,076,000	454,664,000	363,214,000
Other operating	91,943,000	78,154,000	184,400,000	155,583,000
Facility rent	11,328,000	10,570,000	22,693,000	20,918,000
Depreciation and amortization	11,015,000	9,338,000	21,993,000	19,924,000
Total costs and expenses	340,820,000	278,138,000	683,750,000	559,639,000
Income from operations	34,090,000	22,520,000	64,857,000	38,195,000
Other income (expense):
Non–operating income	5,132,000	4,956,000	9,211,000	10,641,000
Interest expense	(1,993,000)	0	(4,099,000)	(46,000)
Unrealized losses on marketable equity securities	(5,061,000)	9,124,000	5,921,000	23,523,000
Income before income taxes	32,168,000	36,600,000	75,890,000	72,313,000
Income tax provision	(8,055,000)	(9,494,000)	(19,487,000)	(18,956,000)
Net income	24,113,000	27,106,000	56,403,000	53,357,000
Net income attributable to noncontrolling interest	(391,000)	(262,000)	(476,000)	(300,000)
Net income attributable to National HealthCare Corporation	$ 23,722,000	$ 26,844,000	$ 55,927,000	$ 53,057,000
Earnings per share attributable to National HealthCare Corporation stockholders:
Basic (in dollars per share)	$ 1.53	$ 1.74	$ 3.62	$ 3.45
Diluted (in dollars per share)	$ 1.52	$ 1.73	$ 3.59	$ 3.42
Weighted average common shares outstanding:
Basic (in shares)	15,462,135	15,391,535	15,450,286	15,371,150
Diluted (in shares)	15,599,638	15,555,612	15,587,783	15,530,624
Dividends declared per common share (in dollars per share)	$ 0.64	$ 0.61	$ 1.25	$ 1.2